Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Gross Profit (2016 - 2025)

Bio-Techne has reported Gross Profit over the past 17 years, most recently at $191.3 million for Q4 2025.

  • Quarterly results put Gross Profit at $191.3 million for Q4 2025, down 1.35% from a year ago — trailing twelve months through Dec 2025 was $792.8 million (up 1.01% YoY), and the annual figure for FY2025 was $790.3 million, up 2.67%.
  • Gross Profit for Q4 2025 was $191.3 million at Bio-Techne, up from $188.1 million in the prior quarter.
  • Over the last five years, Gross Profit for TECH hit a ceiling of $214.6 million in Q1 2025 and a floor of $168.3 million in Q1 2021.
  • Median Gross Profit over the past 5 years was $189.7 million (2025), compared with a mean of $190.5 million.
  • Biggest five-year swings in Gross Profit: surged 55.27% in 2021 and later fell 3.69% in 2023.
  • Bio-Techne's Gross Profit stood at $183.7 million in 2021, then fell by 0.18% to $183.4 million in 2022, then dropped by 3.69% to $176.6 million in 2023, then rose by 9.8% to $193.9 million in 2024, then fell by 1.35% to $191.3 million in 2025.
  • The last three reported values for Gross Profit were $191.3 million (Q4 2025), $188.1 million (Q3 2025), and $198.8 million (Q2 2025) per Business Quant data.